Patent Assignment
Reel/Frame 051101/0371
License
Recorded: 2019-11-25
Pages: 35
Assignee
RELMADA THERAPEUTICS, INC.
880 THIRD AVENUE, 12TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties
(7)
d-Methadone for the Treatment of Psychiatric Symptoms
Application:
61/706,178 →
d-Methadone for the Treatment of Disorders of the Nervous System and their Neurological Symptoms and Manifestations
Application:
62/452,453 →
Dextromethadone (d-Methadone) for Cyto-Protection Against Genetic, Degenerative, Toxic, Traumatic, Ischemic, Infectious and Inflammatory Diseases of Cells and Prevention and Treatment of Their Symptoms
Application:
62/551,948 →
Structurally Modified Opioids for Prevention and Treatment of Diseases
Application:
62/798,709 →
d-Methadone for the Treatment of Psychiatric Symptoms
d-Methadone for the Treatment of Psychiatric Symptoms
Structurally Modified Opioids for Prevention and Treatment of Diseases and Conditions
PCT:
PCT/US2019/055590 ↗
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 9, 2014
From: INTURRISI, CHARLES E; MANFREDI, PAOLO
To: MEDEOR, INC.
Reel/Frame 031930/0779 →
Merger
Aug 28, 2015
From: MEDEOR, INC.
To: RELMADA THERAPEUTICS, INC.
Reel/Frame 036503/0087 →
Assignment of Assignor's Interest
Oct 7, 2016
From: MANFREDI, PAOLO; INTURRISI, CHARLES
To: MEDEOR, INC.
Reel/Frame 039965/0214 →
Merger
Oct 10, 2016
From: MEDEOR, INC.
To: RELMADA THERAPEUTICS, INC.
Reel/Frame 040292/0768 →
Assignment of Assignor's Interest
Mar 16, 2018
From: RELMADA THERAPEUTICS, INC.
To: INTURRISI, CHARLES E; MANFREDI, PAOLO L
Reel/Frame 045250/0876 →